Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2010
03/24/2010CN101679447A pyrimidodiazepinone derivative
03/24/2010CN101679440A Pyrrolopyrimidine derivatives as jak3 inhibitors
03/24/2010CN101679412A Purinones and 1h-imidazopyridinones as PKC-theta inhibitors
03/24/2010CN101679321A Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives
03/24/2010CN101679314A Compound that is a dual inhibitor of enzymes PDE7 and/or PDE4, pharmaceutical compositions and uses thereof
03/24/2010CN101678116A Sialoadhesin-related compositions and methods
03/24/2010CN101678106A Combination of Blys inhibition and/or APRIL inhibition and immunnosuppressants for treatment of autoimmune disease
03/24/2010CN101678104A New indications for anti- il-i-beta therapy
03/24/2010CN101678090A Compositions and methods for the prevention and treatment of autoimmune conditions
03/24/2010CN101678052A Probiotic, gram-positive bacteria for the prophylaxis, suppression, or elimination of allergic reactions in humans
03/24/2010CN101678026A 3, 6-disubstituted-imidazo [1, 2-B] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-A] pyrimidines as phosphatidylinositol-3-kinase inhibitors
03/24/2010CN101678012A An allergen dosage form comprising an antihistamine
03/24/2010CN101677979A Src family kinase inhibitors
03/24/2010CN101676389A Modified vaccinia ankara virus variant
03/24/2010CN101676306A Low molecular weight glucan and preparation method and application thereof
03/24/2010CN101676305A Low molecular weight glucan and preparation method and application thereof
03/24/2010CN101676304A Low-molecular-weight glucan, its preparation method and use
03/24/2010CN101676303A Low-molecular-weight glucan, its preparation method and use
03/24/2010CN101676302A Low molecular weight glucan and preparation method and application thereof
03/24/2010CN101676299A Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament
03/24/2010CN101676286A Azaindoles useful as inhibitors of JAK and other protein kinases
03/24/2010CN101676285A Azaindoles useful as inhibitors of JAK and other protein kinases
03/24/2010CN101676266A Deuterium-substituted omega-diphenylurea and its derivatives, as well as pharmaceutical composition containing the same
03/24/2010CN101676264A Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
03/24/2010CN101675993A melan-a peptide analogue-virus-like-particle conjugates
03/24/2010CN101675986A Lupus III traditional Chinese medicine composition
03/24/2010CN101675983A Warming and tonifying agent for qi-deficiency syndrome
03/24/2010CN101675971A A formula of a traditional Chinese medicine preparation and preparation technology thereof
03/24/2010CN101675969A A traditional Chinese medicinal ointment for treating allergic dermatitis
03/24/2010CN101675967A Lupus I traditional Chinese medicine composition
03/24/2010CN101675960A Lupus II traditional Chinese medicine composition
03/24/2010CN101675945A New use of Mesona chinensis polyphenol extract
03/24/2010CN101675944A Composition containing extract of engelhardtia leaves and preparation method
03/24/2010CN101675942A Honghuoma extract and its preparation method and application
03/24/2010CN101675938A Preparation method and use of a novel peptide type immunizing agent whole-egg protein peptide
03/24/2010CN101675936A Immunosuppressant
03/24/2010CN101675932A Composition for preventing and treating amyotrophic lateral sclerosis
03/24/2010CN101675927A therapeutic molecules and methods-1
03/24/2010CN101675922A Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use
03/24/2010CN100595199C Process for modifying drug crystal formation
03/24/2010CN100594935C Antibodies that immunospecifically bind to trail receptors
03/24/2010CN100594928C Curcuma extract and its prepn process, medicine composition and use
03/24/2010CN100594904C Hydrochloride epinastine dispersing tablets and their production
03/24/2010CN100594894C New formulation for retinoid-containing soft gelatin capsules
03/24/2010CN100594893C Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
03/24/2010CN100594884C Recombination human interferon injection
03/23/2010US7683185 6-(4-Dimethylamino-phenylsulfanyl)-hexa-2,4-dienoic acid methyl ester; stimulating hematopoietic cells ex vivo
03/23/2010US7683164 Nucleic acid derivatives
03/23/2010US7683094 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder
03/23/2010US7683078 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide
03/23/2010US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
03/23/2010US7683061 rheumatoid arthritis, systemic lupus erythematosus (SLE), idiopathic (immune) thrombocytopenia (ITP), glomerulonephritis and vasculitis; reduced drug toxicity
03/23/2010US7682623 Pharmaceutical composition for topical application
03/23/2010CA2446059C Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
03/23/2010CA2418652C Novel 3-substituted urea derivatives and medicinal use thereof
03/23/2010CA2397594C Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
03/23/2010CA2380951C Pharmaceutical compositions for oral and topical administration
03/23/2010CA2377278C Prodrugs of carbamate inhibitors of impdh
03/23/2010CA2353523C Allo and auto-reactive t-cell epitopes
03/23/2010CA2309639C Small peptides and methods for treatment of asthma and inflammation
03/23/2010CA2223412C Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
03/23/2010CA2196656C Method for the preparation of (±)-calanolide a and intermediates thereof
03/23/2010CA2194448C Method of priming an immune response in a one-day old animal
03/18/2010WO2010030979A2 Targeting pathogenic monocytes
03/18/2010WO2010030757A2 Aminopyrimidine inhibitors of histamine receptors for the treatment of disease
03/18/2010WO2010030012A1 ESTERIFIED α-GALACTOSYLCERAMIDE
03/18/2010WO2010030002A1 Cell capable of expressing exogenous gitr ligand
03/18/2010WO2010029435A1 Pd-1 specific antibodies and uses thereof
03/18/2010WO2010029434A1 Pd-1 specific antibodies and uses thereof
03/18/2010WO2010028781A1 8- and 6,8-substituted-2'-deoxyguanosines and uses thereof
03/18/2010WO2010028676A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028675A1 Use of tyrosinase ( 192-200 ) nonapeptide as a therapeutic agent
03/18/2010WO2010028674A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028673A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028672A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028671A1 Use of opiorphin as a therapeutic agent
03/18/2010WO2010028596A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof
03/18/2010WO2010010288A3 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors
03/18/2010WO2009130615A3 Use of deuterium oxide as an elastase inhibitor
03/18/2010US20100071079 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
03/18/2010US20100069492 Production of ultrapure epa and polar lipids from largely heterotrophic culture
03/18/2010US20100069491 Lipid-amino acid conjugates and methods of use
03/18/2010US20100069473 Inhibitors Of IKK-Beta Serine-Threonine Protein Kinase
03/18/2010US20100069457 Naphthalene Derivatives Used As EP4 Receptor Agonists
03/18/2010US20100069454 Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
03/18/2010US20100069447 Benzamide derivatives and uses related thereto
03/18/2010US20100069436 Imidazole compounds having an antiinflammatory effect
03/18/2010US20100069426 Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
03/18/2010US20100069425 Glucocorticoid receptor modulator and methods of use
03/18/2010US20100069407 CXCR2 inhibitors
03/18/2010US20100069367 LXR and FXR Modulators
03/18/2010US20100069361 Fused Thiazole Derivatives as Kinase Inhibitors
03/18/2010US20100069360 Organic compounds
03/18/2010US20100069354 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
03/18/2010US20100069348 Novel compounds as cannabinoid receptor ligands
03/18/2010US20100069343 Methods of predicting steroid responsiveness with Il-1RII
03/18/2010US20100069312 Aminoalkyl glucosamine phosphate compounds for treating autoimmune diseases
03/18/2010US20100069311 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders
03/18/2010US20100069309 Method for medical treatment utilizing glutathione
03/18/2010US20100068263 Method and Compositions for Stimulation of an Immune Response to TRP2 using a Xenogeneic TRP2 Antigen
1 ... 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 ... 1172